This content is machine translated High-risk cardiology patients Facts and Figures on Antithrombotic Therapy Anticoagulation is associated with many challenges – even more so when patients belong to a high-risk group. This is because the combination of different preparations can be associated with risks,…
View Post 3 min This content is machine translated Primary hyperaldosteronism Therapy-resistant hypertension: clarify for Conn syndrome! If high blood pressure cannot be adequately controlled despite antihypertensive drugs, this may be due to undetected hormonal causes. Hypertension due to primary hyperaldosteronism, also known as “Conn syndrome,” is…
View Post 5 min This content is machine translated The metabolic patient Type 2 diabetes: reducing cardiovascular risk through lipid lowering Diabetes is associated with increased cardiovascular risk. Multifactorial therapy of the four major risk factors of blood glucose, weight, hypertension, and dyslipidemia in individuals with type 2 diabetes is challenging.…
View Post 3 min This content is machine translated Type 2 diabetics with overweight Dulaglutide in higher dosage additionally promotes weight reduction GLP-1 receptor agonists not only improve glycemic control but also support weight loss and have also demonstrated additional cardio- and neprotective benefits. Dulaglutide (s.c.) has been successfully used for the…
View Post 4 min This content is machine translated SUSTAIN-10: Post-hoc analysis Semaglutide and liraglutide in type 2 diabetes: effective and safe with and without SGLT-2-i Based on empirical evidence, professional societies recommend early combination of metformin with an SGLT-2 inhibitor or a GLP-1 receptor agonist in type 2 diabetics. Increasingly, a combined application of the…
View Post 10 min This content is machine translated New AGLA guidelines Dyslipidemia – when to see a specialist? “The lower the better” – the approach to lower cholesterol levels as much as possible in patients at cardiovascular risk is more relevant than ever, according to the update of… CME-Test
View Post 2 min This content is machine translated Hypothyroidism What to do with Hashimoto’s thyroiditis? An update Hypothyroidism is a common condition that has significant effects on the body’s metabolic processes. Impaired performance is a result of deficient hormone production by the thyroid gland. Accordingly, thyroid hormone replacement…
View Post 1 min This content is machine translated Diabetes in Motion CME video training on modern diabetes management What aspects need to be considered in diabetes management in family practice beyond blood glucose lowering? How to effectively protect the heart and kidney of diabetic patients? What must the… CME-Test
View Post 8 min This content is machine translated Systemic diseases and the eye Congenital diseases with eye involvement Congenital syndromes may show ocular involvement. These include Down syndrome, Marfan syndrome, myotonic dystrophies, metabolic diseases with lysosomal storage disorders, and neurofibromatosis. The ophthalmological examination is of great relevance, on… CME-Test
View Post 11 min This content is machine translated Hypertension Optimal therapy of hypertension in practice After a confirmed diagnosis of arterial hypertension, one should assess the severity, overall cardiovascular risk, and any organ damage present. First-line antihypertensives are RAAS blockers alone or combined with Ca… CME-Test
View Post 4 min This content is machine translated Modern treatment of type 2 diabetes Combine metformin with new substance classes at an early stage Lifestyle modification alone is usually not sufficient in type 2 diabetes. Metformin is still considered the first-line drug. However, SGED and international professional societies recommend early combination with an SGLT-2…
